sglt2 inhibitors and glp 1 agonist Mechanism of action of diabetes medications on multiple organ systems: SGLT2 Inhibitors and GLP-1 Receptor
Description
A., Heidenreich, K., & Williams, J

This is an unprecedented global health crisis, which imposes a considerable burden on health systems

Elevated levels of triglycerides and free fatty acids in circulation are major factors driving lipid accumulation in the liver, leading to metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis

2017;26(2):343-352E2

doi: 10.1136/gut.38.6.916 [DOI] [PMC free article] [PubMed] [Google Scholar] 23.Campbell JE, Drucker DJ
